The study was conducted in partnership with Abera Bioscience, a platform and vaccine developer with over 30 years of research in the medical, molecular and microbiological fields. Both formulations tested induced strong systemic antibody response in serum (IgG) as well as locally in the...
Hence then, the article about orexo announces positive data for powder based intranasal vaccine formulated with the amorphox technology was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology )
Also on site :
- Claude and Microsoft 365 Copilot AI Agents Named Champions in Info-Tech Research Group's 2026 Agentic AI Platforms Data Quadrant
- PSEG Launches Community Impact Update, Highlights Statewide Community Presence with $12.8 Million in Corporate and Foundation Giving and $16.3 Billion Economic Output in 2025
- Founders Row Partners with Xtend Barre Founder Andrea Rogers to Launch All Day Pilates, a 24/7 Boutique Reformer Studio Powered by Your Reformer